TABLE 1.
Study | Age group | Disease | Study period | No. of centers | No. of strains | No. (%) of strains
|
Reference | |||
---|---|---|---|---|---|---|---|---|---|---|
Eryr | mef(A) positiveb | erm (B) positiveb | mef (A) and erm (B) negativeb | |||||||
A | Children | IPD | 1997-2000 | 123 | 690 | 122 (17.7) | 85 (69.7) | 35 (28.7) | 2 (1.6) | von Kries et al. (25)c |
B | Adults and children | IPD | 1992-2000 | 86 | 3,186 | 226 (7.1) | 117 (51.8) | 107 (47.3) | 2 (0.9) | Reinert et al. (17) |
C | Adults | IPD, RTI | 2001-2002 | 35 | 405 | 51 (12.6) | 24 (47.1) | 26 (51.0) | 1 (2.0) | Felmingham et al. (5) |
Total | 4,281 | 399 (9.3) | 226 (56.6) | 168 (46.6) | 5 (1.3) |
Abbreviations: RTI, respiratory tract infections; IPD, invasive pneumococcal disease; Eryr, erythromycin resistant.
The denominator was the number of macrolide-resistant strains.
Updated data.